• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[阿根廷布宜诺斯艾利斯自治市健康中心项目的健康影响评估]

[Health impact assessment of the Program Healthy Centers in the Autonomous City of Buenos Aires, ArgentinaAvaliação do impacto na saúde do Programa Estações Saudáveis na Cidade Autônoma de Buenos Aires, Argentina].

作者信息

Elorriaga Natalia, Garay Osvaldo Ulises, Belizán María, González Verónica Beatriz, Rossi María Laura, Chaparro Martin, Caporale Joaquín E, Ruggiero Marina De, Antún María Cecilia, Pichon-Riviere Andrés, Rubinstein Adolfo, Irazola Vilma, Augustovski Federico

机构信息

Departamento de Investigación en Enfermedades Crónicas, Instituto de Efectividad Clínica y Sanitaria, Buenos Aires, Argentina.

Departamento de Evaluación de Tecnologías Sa nitarias y Economía de la Salud, Instituto de Efectividad Clínica y Sanitaria, Buenos Aires, Argentina.

出版信息

Rev Panam Salud Publica. 2018 Sep 24;42:e150. doi: 10.26633/RPSP.2018.150. eCollection 2018.

DOI:10.26633/RPSP.2018.150
PMID:31093178
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6386035/
Abstract

OBJECTIVE

To explore the motivations and expectations of the users of the Program for Healthy Centers in the Autonomous City of Buenos Aires and to evaluate its potential health impact.

METHODS

In-depth interviews were conducted (n = 34) and a self-administered survey was sent to users of the program (n = 605). An epidemiological model was developed to estimate the impact of the program on cardiovascular events (CVE) and disability-adjusted life years (DALYs).

RESULTS

The main motivating factors for using the healthy centers were geographic and economic accessibility (free services) and satisfaction with the care received. 14.4% (95% CI, 10.3-18.5%) of hypertensive users and 24.8% (95% CI, 17.6-32.0%) of diabetic users reported having learned of their altered values in the healthy center. More than half of the respondents reported some improvement in their knowledge about the benefits of physical activity and healthy eating; this was more frequent among those who were younger, of lower educational level, users of the public health system, users of a healthy center in the South zone and those who had a cardiometabolic risk factor (p<0.05). It was estimated that the healthy centers would prevent 12.5 cardiovascular and cerebrovascular events per year in the assisted population (4.75 events/100 000) and 47.75 DALYs due to these causes.

CONCLUSIONS

The healthy centers are a favorable space for the implementation of health promotion and prevention actions, contributing to the detection of and facilitating the monitoring of risk factors, with a potential to prevent cardiovascular events and its consequences.

摘要

目的

探讨布宜诺斯艾利斯自治市健康中心项目使用者的动机和期望,并评估其潜在的健康影响。

方法

进行了深入访谈(n = 34),并向该项目的使用者发放了自填式调查问卷(n = 605)。建立了一个流行病学模型来估计该项目对心血管事件(CVE)和伤残调整生命年(DALYs)的影响。

结果

使用健康中心的主要推动因素是地理位置和经济可及性(免费服务)以及对所接受护理的满意度。14.4%(95%置信区间,10.3 - 18.5%)的高血压使用者和24.8%(95%置信区间,17.6 - 32.0%)的糖尿病使用者报告在健康中心得知了自己的异常值。超过一半的受访者表示他们对体育活动和健康饮食益处的了解有所改善;在年龄较小、教育水平较低、公共卫生系统使用者、南区健康中心使用者以及有心血管代谢危险因素的人群中更为常见(p<0.05)。据估计,健康中心每年将在受助人群中预防12.5例心血管和脑血管事件(4.75例/10万)以及因这些原因导致的47.75个伤残调整生命年。

结论

健康中心是实施健康促进和预防行动的有利场所,有助于发现并促进对危险因素的监测,具有预防心血管事件及其后果的潜力。

相似文献

1
[Health impact assessment of the Program Healthy Centers in the Autonomous City of Buenos Aires, ArgentinaAvaliação do impacto na saúde do Programa Estações Saudáveis na Cidade Autônoma de Buenos Aires, Argentina].[阿根廷布宜诺斯艾利斯自治市健康中心项目的健康影响评估]
Rev Panam Salud Publica. 2018 Sep 24;42:e150. doi: 10.26633/RPSP.2018.150. eCollection 2018.
2
Prevalence of multiple sclerosis in Buenos Aires, Argentina using the capture-recapture method.采用捕获-再捕获法对阿根廷布宜诺斯艾利斯多发性硬化症患病率的研究
Eur J Neurol. 2009 Feb;16(2):183-7. doi: 10.1111/j.1468-1331.2008.02375.x. Epub 2008 Dec 9.
3
[Evaluation of the first level of care for tuberculosis control in Buenos Aires, ArgentinaAvaliação da atenção primária à saúde no controle da tuberculose em Buenos Aires, Argentina].[阿根廷布宜诺斯艾利斯结核病控制一级护理评估]
Rev Panam Salud Publica. 2020 Dec 14;44:e156. doi: 10.26633/RPSP.2020.156. eCollection 2020.
4
[Psychotropic medication consumption in the general population of Buenos Aires City, Argentina. Comparison 2005-2017].[阿根廷布宜诺斯艾利斯市普通人群的精神药物消费情况。2005 - 2017年比较]
Vertex. 2018 Nov;XXIX(142):313-318.
5
Survey on the extubation procedure in intensive care units in Buenos Aires, Argentina.阿根廷布宜诺斯艾利斯重症监护病房拔管程序调查
Rev Bras Ter Intensiva. 2019 May 23;31(2):180-185. doi: 10.5935/0103-507X.20190027.
6
Increasing prevalence of multiple sclerosis in Buenos Aires, Argentina.阿根廷布宜诺斯艾利斯多发性硬化症发病率上升。
Mult Scler Relat Disord. 2016 Sep;9:91-4. doi: 10.1016/j.msard.2016.07.007. Epub 2016 Jul 9.
7
Infant mortality in the Matanza-Riachuelo River Basin. Comparison with the Autonomous City of Buenos Aires, the province of Buenos Aires, and Argentina (2010-2017).马坦萨-拉伊科雷亚河流域婴儿死亡率。与布宜诺斯艾利斯自治市、布宜诺斯艾利斯省和阿根廷(2010-2017 年)的比较。
Arch Argent Pediatr. 2020 Oct;118(5):313-319. doi: 10.5546/aap.2020.eng.313.
8
Commentary on: "Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): A multicentre, randomised, double-blind, phase 3 trial." Kwon ED, Drake CG, Scher HI, Fizazi K, Bossi A, van den Eertwegh AJ, Krainer M, Houede N, Santos R, Mahammedi H, Ng S, Maio M, Franke FA, Sundar S, Agarwal N, Bergman AM, Ciuleanu TE, Korbenfeld E, Sengeløv L, Hansen S, Logothetis C, Beer TM, McHenry MB, Gagnier P, Liu D, Gerritsen WR, CA184-043 Investigators. Departments of Urology and Immunology and Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA, Electronic address: kwon.eugene@mayo.edu; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Brady Urological Institute, Baltimore, MD, USA; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA; Institut Gustave Roussy, University of Paris-Sud, Villejuif, France; Institut Gustave Roussy, Villejuif, France; VU University Medical Centre, Amsterdam, Netherlands; Vienna General Hospital, Medical University Vienna, Vienna, Austria; Institut Bergonié, Bordeaux, France; CHU Caremeau, Nimes, France; Centro Médico Austral, Buenos Aires, Argentina; Centre Jean Perrin, Clermont-Ferrand, France; St John of God Hospital, Subiaco, WA, Australia; University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy; Hospital de Caridade de Ijuí, Ijuí, Brazil; Nottingham University Hospital, Nottingham, UK; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA; Netherlands Cancer Institute and Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Institute of Oncology Ion Chiricuta and University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania; Hospital Británico de Buenos Aires, Buenos Aires, Argentina; Herlev Hospital, Herlev, Denmark; Odense University Hospital, Odense, Denmark; University of Texas MD Anderson Cancer Center, Houston,关于“多西他赛化疗后进展的转移性去势抵抗性前列腺癌患者放疗后伊匹木单抗与安慰剂对比研究(CA184 - 043):一项多中心、随机、双盲、3期试验”的述评。权恩东(Kwon ED)、德雷克·C·G(Drake CG)、舍尔·H·I(Scher HI)、菲扎齐·K(Fizazi K)、博西·A(Bossi A)、范登·埃尔特韦赫·A·J(van den Eertwegh AJ)、克莱纳·M(Krainer M)、胡德·N(Houede N)、桑托斯·R(Santos R)、马哈梅迪·H(Mahammedi H)、吴思(Ng S)、马约·M(Maio M)、弗兰克·F·A(Franke FA)、桑达尔·S(Sundar S)、阿加瓦尔·N(Agarwal N)、伯格曼·A·M(Bergman AM)、丘莱亚努·T·E(Ciuleanu TE)、科尔本费尔德·E(Korbenfeld E)、森格洛夫·L(Sengeløv L)、汉森·S(Hansen S)、洛戈塞蒂斯·C(Logothetis C)、比尔·T·M(Beer TM)、麦克亨利·M·B(McHenry MB)、加尼耶·P(Gagnier P)、刘丹(Liu D)、格里特森·W·R(Gerritsen WR),CA184 - 043研究团队。美国明尼苏达州罗切斯特市梅奥诊所泌尿外科、免疫学系及梅奥诊所综合癌症中心,电子邮箱:kwon.eugene@mayo.edu;美国马里兰州巴尔的摩市约翰·霍普金斯西德尼·金梅尔综合癌症中心及布雷迪泌尿外科研究所;美国纽约州纽约市纪念斯隆凯特琳癌症中心及威尔康乃尔医学院;法国巴黎 - 萨克雷大学古斯塔夫·鲁西研究所,维勒瑞夫;法国古斯塔夫·鲁西研究所,维勒瑞夫;荷兰阿姆斯特丹VU大学医学中心;奥地利维也纳医科大学维也纳总医院;法国波尔多贝戈涅研究所;法国尼姆卡勒莫医院;阿根廷布宜诺斯艾利斯澳大利亚医学中心;法国克莱蒙费朗让·佩兰中心;澳大利亚西澳大利亚州苏比亚科圣若翰医院;意大利锡耶纳大学医院、托斯卡纳肿瘤研究所;巴西伊茹伊慈善医院;英国诺丁汉大学医院;美国犹他州盐湖城犹他大学亨茨曼癌症研究所;荷兰阿姆斯特丹荷兰癌症研究所及安东尼·范·列文虎克医院;罗马尼亚克卢日 - 纳波卡肿瘤研究所及尤利乌·哈蒂根努医科药学院;阿根廷布宜诺斯艾利斯英国医院;丹麦赫勒夫医院;丹麦欧登塞大学医院;美国得克萨斯大学MD安德森癌症中心,休斯顿
Urol Oncol. 2016 May;34(5):249-50. doi: 10.1016/j.urolonc.2015.03.013. Epub 2015 Apr 20.
9
Hepatitis C virus diversification in Argentina: comparative analysis between the large city of Buenos Aires and the small rural town of O'Brien.阿根廷丙型肝炎病毒的多样化:布宜诺斯艾利斯大城市与奥布赖恩小镇的比较分析。
PLoS One. 2013 Dec 30;8(12):e84007. doi: 10.1371/journal.pone.0084007. eCollection 2013.
10
Incidence and prevalence of amyotrophic lateral sclerosis in an HMO of Buenos Aires, Argentina.阿根廷布宜诺斯艾利斯 HMO 中肌萎缩侧索硬化症的发病率和患病率。
Amyotroph Lateral Scler Frontotemporal Degener. 2013 Dec;14(7-8):598-603. doi: 10.3109/21678421.2013.808225. Epub 2013 Jul 8.

引用本文的文献

1
Sustainability in chronic disease prevention: lessons from the program in Ecuador.慢性病预防中的可持续性:来自厄瓜多尔项目的经验教训。
Rev Panam Salud Publica. 2021 Feb 23;45:e30. doi: 10.26633/RPSP.2021.30. eCollection 2021.
2
[Sustainability in chronic disease prevention: lessons from the Salud al Paso program in Ecuador].[慢性病预防中的可持续性:来自厄瓜多尔萨卢德阿尔帕索项目的经验教训]
Rev Panam Salud Publica. 2020 Dec 14;44:e113. doi: 10.26633/RPSP.2020.113. eCollection 2020.

本文引用的文献

1
Obesogenic environments: current evidence of the built and food environments.致胖环境:建筑环境与食物环境的当前证据
Perspect Public Health. 2017 Jan;137(1):38-44. doi: 10.1177/1757913916679860.
2
Eliminating artificial trans fatty acids in Argentina: estimated effects on the burden of coronary heart disease and costs.阿根廷消除人造反式脂肪酸:对冠心病负担和成本的估计影响。
Bull World Health Organ. 2015 Sep 1;93(9):614-22. doi: 10.2471/BLT.14.150516. Epub 2015 Jun 23.
3
Multiple cardiometabolic risk factors in the Southern Cone of Latin America: a population-based study in Argentina, Chile, and Uruguay.拉丁美洲南锥体地区的多种心血管代谢危险因素:一项基于阿根廷、智利和乌拉圭人群的研究。
Int J Cardiol. 2015 Mar 15;183:82-8. doi: 10.1016/j.ijcard.2015.01.062. Epub 2015 Jan 27.
4
Behavioral counseling to promote a healthy lifestyle in persons with cardiovascular risk factors: a systematic review for the U.S. Preventive Services Task Force.行为咨询以促进心血管危险因素患者的健康生活方式:美国预防服务工作组的系统评价。
Ann Intern Med. 2014 Oct 21;161(8):568-78. doi: 10.7326/M14-0130.
5
Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010.1990-2010 年期间首次发生的缺血性和出血性卒中的全球和区域负担:来自 2010 年全球疾病负担研究的结果。
Lancet Glob Health. 2013 Nov;1(5):e259-81. doi: 10.1016/S2214-109X(13)70089-5. Epub 2013 Oct 24.
6
Nursing interventions for smoking cessation.戒烟的护理干预措施。
Cochrane Database Syst Rev. 2013 Aug 12(8):CD001188. doi: 10.1002/14651858.CD001188.pub4.
7
Assessing the global burden of ischemic heart disease, part 2: analytic methods and estimates of the global epidemiology of ischemic heart disease in 2010.评估缺血性心脏病的全球负担,第2部分:分析方法及2010年缺血性心脏病全球流行病学估计
Glob Heart. 2012 Dec 1;7(4):331-342. doi: 10.1016/j.gheart.2012.10.003. Epub 2012 Dec 5.
8
Modeling good research practices--overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1.建立良好研究实践模型——概述:ISPOR-SMDM 建立良好研究实践工作组 1 的报告。
Med Decis Making. 2012 Sep-Oct;32(5):667-77. doi: 10.1177/0272989X12454577.
9
Sudden cardiac death caused by coronary heart disease.冠心病导致的心脏性猝死。
Circulation. 2012 Feb 28;125(8):1043-52. doi: 10.1161/CIRCULATIONAHA.111.023846.
10
Self-monitoring and other non-pharmacological interventions to improve the management of hypertension in primary care: a systematic review.自我监测和其他非药物干预措施以改善初级保健中的高血压管理:系统评价。
Br J Gen Pract. 2010 Dec;60(581):e476-88. doi: 10.3399/bjgp10X544113.